Financhill
Back

Aurinia Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

AUPH
Aurinia Pharmaceuticals, Inc.

Last Price:
$14.40
Seasonality Move:
7.28%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight buying pressure.

Aurinia Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.4 Buy
20-day SMA: 14.56 Sell
50-day SMA: 15.18 Sell
200-day SMA: 12.06 Buy
8-day EMA: 14.4 Buy
20-day EMA: 14.59 Sell
50-day EMA: 14.76 Sell
200-day EMA: 12.66 Buy

Aurinia Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 43.19 Sell
Chaikin Money Flow: 246249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.35 - 14.91) Sell
Bollinger Bands (100): (12.65 - 15.97) Buy

Aurinia Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Aurinia Pharmaceuticals, Inc. Stock

Is Aurinia Pharmaceuticals, Inc. Stock a Buy?

AUPH Technical Analysis vs Fundamental Analysis

Buy
58
Aurinia Pharmaceuticals, Inc. (AUPH) is a Buy

Is Aurinia Pharmaceuticals, Inc. a Buy or a Sell?

Aurinia Pharmaceuticals, Inc. Stock Info

Market Cap:
1.9B
Price in USD:
14.40
Share Volume:
519.9K

Aurinia Pharmaceuticals, Inc. 52-Week Range

52-Week High:
16.54
52-Week Low:
6.55
Buy
58
Aurinia Pharmaceuticals, Inc. (AUPH) is a Buy

Aurinia Pharmaceuticals, Inc. Share Price Forecast

Is Aurinia Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Aurinia Pharmaceuticals, Inc.

Is Aurinia Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.13 per share.

Technical Analysis of Aurinia Pharmaceuticals, Inc.

Should I short Aurinia Pharmaceuticals, Inc. stock?

* Aurinia Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.